文献速递头颈外科

头颈部汗腺腺癌:罕见疾病的群体视角研究

Head and neck sweat gland adenocarcinoma: A population-based perspective of a rare entity.
PubMed 文献 · Laryngoscope · 2017-04-11

该研究基于监测、流行病学和最终结果(SEER)登记处2000至2013年数据,提取627例头颈部汗腺腺癌(HNSGA)病例进行回顾性群体分析。结果显示总体5年、10年和20年疾病特异性生存(DSS)分别为94.6%、89.6%和79.8%,不良预后因素包括年龄较大、肿瘤分级较高、侵犯范围更广以及原发部位为头皮或颈部。

要点

  • HNSGA发病率极低(0.036/10万),最常见于白人男性60-79岁,面部皮肤为最常见原发部位(43.4%)。
  • 总体5年、10年、20年DSS分别为94.6%、89.6%、79.8%。
  • 区域和远处病变、分级III/IV、头皮或颈部原发部位预示更差DSS。

核心结论

  • 年龄较大、肿瘤分级较高、侵犯范围更广以及原发部位为头皮或颈部是显著的不良预后指标。

研究设计与样本

  • 回顾性群体分析,利用SEER登记处2000至2013年数据,提取627例HNSGA病例。
  • 证据等级为4级。

主要发现

  • 大多数HNSGA病例为白人、男性、60至79岁,发病率为0.036/10万。
  • 肿瘤多表现为局限性疾病和组织学II/III级,面部皮肤为最常见原发部位(43.4%),其次为头皮和颈部(31.6%)。
  • 总体5年、10年和20年DSS分别为94.6%、89.6%和79.8%。
  • 种族不影响生存,而诊断时较年轻和女性分别在10年(P=0.0386)和5年(P=0.0191)生存上具有优势。
  • HNSGA起源(大汗腺 vs. 小汗腺)不影响结局;区域和远处病变预示5年、10年和20年DSS更差(P=0.0026,P<0.001,P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Head and neck sweat gland adenocarcinoma (HNSGA) is an extremely rare malignancy. We present the first population-based analysis regarding this entity. STUDY DESIGN: Retrospective population-based analysis. METHODS: Using the Surveillance, Epidemiology, and End Results registry from 2000 to 2013, we extracted 627 cases of HNSGA. Data were analyzed for incidence trends, demographic and clinicopathologic traits, and predictors of disease-specific survival (DSS). RESULTS: The majority HNSGA cases were white, male, and 60 to 79 years old. The incidence was 0.036 per 100,000 people. Tumors most often presented as localized disease and histological grade II/III. The skin of the face was the most common primary site (43.4%), followed by the scalp and neck (31.6%). Overall 5-, 10-, and 20-year DSS were 94.6%, 89.6%, and 79.8%, respectively. Ethnicity did not affect survival, whereas a younger age at diagnosis and female sex conferred an advantage at 10 years (P = 0.0386) and 5 years (P = 0.0191), respectively. The origin of the HNSGA (apocrine vs. eccrine) did not affect outcomes. Regional and distant disease predicted worse DSS at 5, 10, and 20 years (P = 0.0026, P < 0.001, P < 0.001, respectively). Compared to grade I/II disease, grade III/IV dramatically worsened 5-, 10-, and 20-year DSS (P = 0.0035, P < 0.0001, P = 0.0011, respectively). Scalp and neck HNSGA exhibited the poorest 20-year DSS compared to other primary sites (P = 0.0024). CONCLUSION: We present the largest cohort of HNSGA. Significant poor prognostic indicators include older age, higher tumor grade, greater extent of invasion, and primary site of the scalp or neck. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2757-2762, 2017.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Unsal AA, Patel VR, Chung SY, et al. Head and neck sweat gland adenocarcinoma: A population-based perspective of a rare entity. Laryngoscope. 2017. PMID: 28397272. doi:10.1002/lary.26593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。